Shamans, sacraments, and psychiatrists

Area of Science:

• Psychiatry
• Psychopharmacology
• Neuroscience

Background:

• Psychedelic drug use in psychiatry declined due to social stigma and legal controls.
• Historical research explored various paradigms for psychedelic use in mental health.

Observation:

• The psychotomimetic paradigm, viewing psychedelics as psychosis inducers, offered limited clinical value.
• The psycholytic approach used low doses to reduce defenses and access unconscious material.
• High-dose psychedelic experiences were often mystical, leading to varied psychiatric reception.

Findings:

• Different psychedelic paradigms (psychotomimetic, psycholytic, psychedelic) yielded varying results in psychiatric applications.
• The high-dose psychedelic model, despite its potential for profound experiences, faced professional skepticism.

Implications:

• Future sanctioned clinical research with psychedelics requires learning from historical models, including shamanic practices.
• Optimizing the assessment of psychedelic efficacy and safety necessitates a nuanced understanding of their unique psychoactive properties.